GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

Tidak ada perdagangan
Lihat pada chart super

Obligasi GSKD

Berikut ini adalah daftar obligasi korporasi GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs. Investor sering memilih obligasi perusahaan karena stabilitasnya yang lebih baik di saat pasar bergejolak. Pelajari harga, imbal hasil, dan statistik mereka lainnya dan temukan investasi yang dapat diandalkan.
Simbol
YTM %
Volume
Harga %
Kupon %
Tanggal Jatuh Tempo
Jumlah yang belum dibayar
Nilai nominal
Jumlah denominasi minimum
Penerbit
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
250 K88,04%4,20%2043-03-18500 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027
96 K100,15%4,86%2027-03-12600 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
436 K113,34%6,38%2038-05-152,75 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
80 K100,80%4,32%2027-03-12400 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
35 K101,49%4,88%2035-04-15750 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
137 K101,85%4,50%2030-04-15850 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026
099,39%1,25%2026-05-211 B EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS293369275GSK Capital BV 3.25% 19-NOV-2036
097,42%3,25%2036-11-19600 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028
091,78%1,25%2028-10-12750 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030
095,29%1,75%2030-05-21750 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026
098,81%1,00%2026-09-12700 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028
099,86%3,88%2028-05-151,75 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029
097,81%3,38%2029-06-011 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029
095,24%1,38%2029-09-12500 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS293369143GSK Capital BV 2.875% 19-NOV-2031
099,16%2,88%2031-11-19700 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035
073,10%1,63%2035-05-12750 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
XXS255381768GSK Capital BV 3.0% 28-NOV-2027
0101,21%3,00%2027-11-28500 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS255381776GSK Capital BV 3.125% 28-NOV-2032
099,80%3,13%2032-11-28700 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-20390107,50%6,38%2039-03-09631,3 M GBP1.000,00 GBP50.000,00 GBPGlaxoSmithKline Capital Plc
772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-20340105,28%5,38%2034-04-15500 M USD1.000,00 USD1.000,00 USDGlaxoSmithKline Capital, Inc.
117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-20270112,19%3,38%2027-12-20307,77 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-20330103,48%5,25%2033-12-19574,17 M GBP1.000,00 GBP1.000,00 GBPGlaxoSmithKline Capital Plc
117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-20458,46 K82,51%4,25%2045-12-18370,79 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-20280,88%2028-09-2142,5 B JPY100.000.000,00 JPY100.000.000,00 JPYGlaxoSmithKline Capital Plc
883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-2042094,53%5,25%2042-04-10477,82 M GBP1.000,00 GBP50.000,00 GBPGlaxoSmithKline Capital Plc